R01 DK076852/DK/NIDDK NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2006	1
2008	2
2009	8
2010	4
2011	5
2012	7
2013	7
2014	12
2015	2
2016	1
2017	1
2018	1
2024	0

1

Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?

Alkhouri N, Feldstein AE. Alkhouri N, et al. Metabolism. 2016 Aug;65(8):1087-95. doi: 10.1016/j.metabol.2016.01.013. Epub 2016 Feb 2. Metabolism. 2016. PMID: 26972222 Free PMC article. Review.

2

Adipocyte cell death, fatty liver disease and associated metabolic disorders.

Eguchi A, Feldstein AE. Eguchi A, et al. Dig Dis. 2014;32(5):579-85. doi: 10.1159/000360509. Epub 2014 Jul 14. Dig Dis. 2014. PMID: 25034291 Free PMC article. Review.

3

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

Alkhouri N, Carter-Kent C, Feldstein AE. Alkhouri N, et al. Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):201-12. doi: 10.1586/egh.11.6. Expert Rev Gastroenterol Hepatol. 2011. PMID: 21476915 Free PMC article. Review.

4

Obesity, nutrition, and liver disease in children.

Feldstein AE, Patton-Ku D, Boutelle KN. Feldstein AE, et al. Clin Liver Dis. 2014 Feb;18(1):219-31. doi: 10.1016/j.cld.2013.09.003. Clin Liver Dis. 2014. PMID: 24274876 Free PMC article. Review.

5

Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal.

Alkhouri N, Dixon LJ, Feldstein AE. Alkhouri N, et al. Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):445-51. doi: 10.1586/egh.09.32. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19673631 Free PMC article. Review.

6

Biomarkers in nonalcoholic fatty liver disease: a new era in diagnosis and staging of disease in children.

Feldstein AE, Nobili V. Feldstein AE, et al. J Pediatr Gastroenterol Nutr. 2010 Oct;51(4):378-9. doi: 10.1097/MPG.0b013e3181ecf3d4. J Pediatr Gastroenterol Nutr. 2010. PMID: 20808243 Free PMC article. No abstract available.

7

Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease.

Alkhouri N, Carter-Kent C, Elias M, Feldstein AE. Alkhouri N, et al. Clin Lipidol. 2011 Jun 1;6(3):305-314. doi: 10.2217/clp.11.19. Clin Lipidol. 2011. PMID: 22162978 Free PMC article.

8

Lysosomal Cathepsin D contributes to cell death during adipocyte hypertrophy.

Eguchi A, Feldstein AE. Eguchi A, et al. Adipocyte. 2013 Jul 1;2(3):170-5. doi: 10.4161/adip.24144. Epub 2013 Apr 19. Adipocyte. 2013. PMID: 23991364 Free PMC article.

9

Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease.

Alkhouri N, Lopez R, Berk M, Feldstein AE. Alkhouri N, et al. J Clin Gastroenterol. 2009 Nov-Dec;43(10):985-9. doi: 10.1097/MCG.0b013e3181a0998d. J Clin Gastroenterol. 2009. PMID: 19525859 Free PMC article.

10

NLRP3 inflammasome activation is required for fibrosis development in NAFLD.

Wree A, McGeough MD, Peña CA, Schlattjan M, Li H, Inzaugarat ME, Messer K, Canbay A, Hoffman HM, Feldstein AE. Wree A, et al. J Mol Med (Berl). 2014 Oct;92(10):1069-82. doi: 10.1007/s00109-014-1170-1. Epub 2014 May 28. J Mol Med (Berl). 2014. PMID: 24861026 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year